Joining The Alliance for Regenerative Medicine
CombiGene has been invited to join 240+ other gene and cell therapy and other regenerative medicine-focused organizations to become a part of The Alliance for Regenerative Medicine (ARM).ARM is based in Washington, D.C. and promotes legislative, regulatory and reimbursement initiatives facilitating advances in gene and cellular therapies and other regenerative medicines worldwide. CombiGene CEO Bengt Westrin comments: “By joining ARM we will access an international, cutting-edge network within gene therapy, and it will also help us reaching out to business development and investment